Diagnostic value of mitochondrial DNA analysis in Chronic Progressive External Ophthalmoplegia (CPEO);Bedeutung der mitochondrialen DNA-analyse in der diagnostik der chronisch-progressiven externen Ophthalmoplegie (CPEO)

Klinische Monatsblatter fur Augenheilkunde

Volumn 221, Issue 12, 2004, Pages 1057-1061

  Kornblum, C ^a   Kunz, W S ^a   Klockgether, T ^a   Roggenkamper P ^a   Schroder R ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

CPEO; Diplopia; Mitochondrial DNA deletion

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CASE REPORT; CHEMICAL ANALYSIS; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DIAGNOSTIC VALUE; DIPLOPIA; DNA DETERMINATION; EYE MOVEMENT DISORDER; FEMALE; GENE DELETION; HETEROPLASMY; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MUSCLE BIOPSY; NEUROLOGIC EXAMINATION; PTOSIS; SOUTHERN BLOTTING;

ADULT; BIOPSY; BLEPHAROPTOSIS; BLOTTING, SOUTHERN; CHROMOSOME DELETION; DIAGNOSIS, DIFFERENTIAL; DIPLOPIA; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OCULAR MOTILITY DISORDERS; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL;

EID: 11244341087     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813830     Document Type: Article

References (14)

1. Biousse V, Newman NJ. Neuro-ophthalmology of mitochondrial diseases. Current Opinion in Neurology 2003; 16: 35-43
2. Chinnery PF, Turnbull DM. Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry 1997; 63: 559-563
3. DiMauro S, Andreu AL, Musumeci O et al. Diseases of oxidative phosphorylation due to mtDNA mutations. Semin Neurol 2001; 21: 251-260
4. Dubovitz V. Muscle biopsy. A practical approach. London: Baillière Tindall, 1985: Second edition
5. Hayashi J, Ohta S, Kikuchi A et al. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A 1991; 88: 10 614-10 618
6. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331 (6158): 717-719
7. Leonard JV, Schapira AHV. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 2000; 355: 299-304
8. Mariotti C, Savarese N, Suomalainen A et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 1995; 242 (5): 304-312
9. Okulla T, Kunz W, Klockgether T et al. Diagnostic value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis. Graef Arch Clin Exp, 2004, Oct 13 (epub), in press
10. Schmiedel J, Jackson S, Schäfer J et al. Mitochondrial cytopathies. J Neurol 2003; 250: 267-277
11. Schröder R, Vielhaber S, Wiedemann FR et al. New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle. J Neuropathol Exp Neurol 2000; 59: 353-360
12. Simon DK, Johns DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med 1999; 50: 111-127
13. Sommer F, Fötzsch R, Pillunat LE et al. Chronisch progressive externe Ophthalmoplegie (CPEO) - diagnostische und therapeutische Probleme. Klin Monatsbl Augenheilkd 2003; 220: 315-319
14. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283: 1482-1488